Skip to main content
    C

    China Pharma Holdings Inc (CPHI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX

    $0.52
    -0.04 (-7.47%)

    Market Cap: $22.29M

    Last updated: Nov 17, 2026 at 10:59 AM ET

    China Pharma Holdings Inc (CPHI) Earnings: Report Dates and Results

    Updated Aug 14, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Jun 30, 2026, China Pharma Holdings reported EPS of -$0.04. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.

    Earnings

    Next Report

    CPHI's next report is not on the earnings calendar yet.

    Earnings History

    Revenue for the quarter ended Jun 30, 2026 was $948340, down 7.9% from $1.03M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026-$0.04N/AN/AN/AN/AN/AN/AN/AAug 14, 2026$948340
    Sep 30, 2025-$0.17N/AN/AN/AN/AN/AN/AN/ANov 12, 2025$756217
    Jun 30, 2025-$0.16N/AN/AN/AN/AN/AN/AN/AAug 14, 2025$1.03M
    Mar 31, 2025-$0.24N/AN/AN/AN/AN/AN/AN/AMay 14, 2025$1.14M
    Dec 31, 2024-$0.53N/AN/AN/AN/AN/AN/AN/AMar 31, 2025$1.13M
    Sep 30, 2024-$0.65N/AN/AN/AN/AN/AN/AN/ANov 18, 2024$1.10M
    Jun 30, 2024-$0.89N/AN/AN/AN/AN/AN/AN/AAug 14, 2024$924943
    Mar 31, 2024-$0.73N/AN/AN/AN/AN/AN/AN/AApr 1, 2024$1.37M
    Dec 31, 2023-$1.16N/AN/AN/AN/AN/AN/AN/AFeb 28, 2024$2.15M
    Sep 30, 2023-$2.94N/AN/AN/AN/AN/AN/AN/ANov 13, 2023$1.80M
    Jun 30, 2023-$2.99N/AN/AN/AN/AN/AN/AN/AAug 14, 2023$1.10M
    Mar 31, 2023-$0.06N/AN/AN/AN/AN/AN/AN/AMay 12, 2023$1.96M
    Dec 31, 2022-$0.20N/AN/AN/AN/AN/AN/AN/AMar 30, 2023$2.92M
    Sep 30, 2022-$0.02N/AN/AN/AN/AN/AN/AN/ANov 14, 2022$1.97M
    Jun 30, 2022-$0.02N/AN/AN/AN/AN/AN/AN/AAug 11, 2022$1.61M
    Mar 31, 2022-$0.02N/AN/AN/AN/AN/AN/AN/AMay 12, 2022$1.60M
    Dec 31, 2021-$0.02N/AN/AN/AN/AN/AN/AN/AMar 31, 2022$2.89M
    Sep 30, 2021-$0.02N/AN/AN/AN/AN/AN/AN/ANov 12, 2021$1.98M
    Jun 30, 2021-$0.02N/AN/AN/AN/AN/AN/AN/AAug 13, 2021$2.42M
    Mar 31, 2021-$0.02N/AN/AN/AN/AN/AN/AN/AMay 14, 2021$2.36M
    Dec 31, 2020-$0.03N/AN/AN/AN/AN/AN/AN/AMar 26, 2021$2.93M
    Sep 30, 2020-$0.02N/AN/AN/AN/AN/AN/AN/ANov 13, 2020$2.40M
    Jun 30, 2020-$0.02N/AN/AN/AN/AN/AN/AN/AAug 14, 2020$3.77M
    Mar 31, 2020-$0.02N/AN/AN/AN/AN/AN/AN/AMay 15, 2020$1.76M
    Dec 31, 2019-$0.43N/AN/AN/AN/AN/AN/AN/AFeb 26, 2020$3.05M
    Sep 30, 2019-$0.02N/AN/AN/AN/AN/AN/AN/ANov 15, 2019$2.38M
    Jun 30, 2019-$0.02N/AN/AN/AN/AN/AN/AN/AAug 15, 2019$2.57M
    Mar 31, 2019-$0.17N/AN/AN/AN/AN/AN/AN/AMay 15, 2019$2.93M
    Dec 31, 2018-$0.01N/AN/AN/AN/AN/AN/AN/AMar 29, 2019$3.24M
    Sep 30, 2018-$0.04N/AN/AN/AN/AN/AN/AN/ANov 15, 2018$2.30M
    Jun 30, 2018-$0.02N/AN/AN/AN/AN/AN/AN/AAug 15, 2018$3.17M
    Mar 31, 2018-$0.32N/AN/AN/AN/AN/AN/AN/AApr 3, 2018$3.62M
    Dec 31, 2017-$0.01N/AN/AN/AN/AN/AN/AN/AMar 31, 2018$3.85M
    Sep 30, 2017-$0.05N/AN/AN/AN/A-162.5%N/AN/ANov 15, 2017$3.16M
    Jun 30, 2017-$0.05N/AN/AN/AN/A-162.5%N/AN/AAug 15, 2017$2.92M
    Mar 31, 2017-$0.02N/AN/AN/AN/AN/AN/AN/AMay 12, 2017$3.29M
    Dec 31, 2016-$0.02N/AN/AN/AN/A-127.7%N/AN/AMar 31, 2017$5.26M
    Sep 30, 2016$0.08N/AN/AN/AN/A0.0%N/AN/ANov 15, 2016$3.13M
    Jun 30, 2016$0.08N/AN/AN/AN/A+18.9%N/AN/AAug 11, 2016$3.54M
    Mar 31, 2016-$0.06N/AN/AN/AN/AN/AN/AN/AMay 17, 2016$3.64M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2024 was -$2.80, after -$7.15 the year before. It was $0.13 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2024-$2.80N/A
    Dec 31, 2023-$7.15N/A
    Dec 31, 2022-$0.26N/A
    Dec 31, 2021-$0.08N/A
    Dec 31, 2020-$0.09N/A
    Dec 31, 2019-$0.64N/A
    Dec 31, 2018-$0.39N/A
    Dec 31, 2017-$0.13-255.5%
    Dec 31, 2016$0.08-38.7%
    Dec 31, 2015$0.13N/A

    Frequently Asked Questions About CPHI

    How often does CPHI beat earnings estimates?

    China Pharma Holdings beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of -3.08%.